News
According to the Financial Times, MSD – known as Merck & Co in the US and Canada – is in the final stages of a $10 billion ...
US drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung diseases, the Financial Times reported today.
Merck is nearing a $10 billion deal to buy lung diseases focussed Verona Pharma, as the U.S. drugmaker is eyeing deals to ...
U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results